Suneil H.

Suneil H. is an experienced professional in the life sciences sector, currently serving as Vice President of Diagnostic Strategy at Madrigal Pharmaceuticals since February 2024. Prior roles include Vice President of Clinical and Translational Biomarker Strategy at Neurogene Inc. and Global Head of Diagnostics at GENFIT, where Suneil led the commercialization of a molecular blood-based diagnostic test and contributed to a successful initial public offering. Suneil has held strategic positions at Echosens, Intercept Pharmaceuticals, and BD, focusing on developing and executing innovative diagnostic strategies and commercial initiatives. Suneil holds a PhD in Biomedical Engineering from The Johns Hopkins University School of Medicine and both a BS and MS in Electrical and Computer Engineering from the University of Illinois Urbana-Champaign.